List of medicinal products marketed by LFB BIOMEDICAMENTS, in France. (By alphabetical order): ACLOTINE® 100 IU ml – Human antithrombin ALFALASTIN® 33.33 mg ml – Human alpha-1 antitrypsin - X Factor - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-02-11 10:35:59 Biology Thrombin Coagulation Antithrombin Von Willebrand disease Factor X Factor VIII CSL Behring CSL Limited Coagulation system Blood Anatomy		List of medicinal products marketed by LFB BIOMEDICAMENTS, in France. (By alphabetical order): ACLOTINE® 100 IU/ml – Human antithrombin ALFALASTIN® 33.33 mg/ml – Human alpha-1 antitrypsin Add to Reading List Source URL: www.lfb.fr Download Document from Source Website File Size: 38,77 KB Share Document on Facebook

	CSL Behring AG WankdorfstrasseBern 22 Switzerland sitem-insel AG DocID: 1uREs - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1sx8q - View Document
	Uwe E. Jocham Direktionspräsident CSL Behring Recombinant Facility AG, Lengnau/Schweiz Uwe E. Jocham, geboren in Frankfurt, Deutschland, studierte Pharmazie an der LudwigMaximilians-Universität (LMU) in München. Nach DocID: 1sesH - View Document
	MAJOR THERAPEUTIC PRODUCTS MARKETED by CSL Behring Hematology Specialty Care DocID: 1sb17 - View Document
	[Product Monograph Template - Schedule D] DocID: 1rjWd - View Document